Stock NEOS NEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Neos Therapeutics, Inc.

Equities

NEOS

US64052L1061

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Aytu Biopharma, Inc. Enters into Loan and Security Agreement, by and Among Neos Therapeutics, Inc., Neos Therapeutics Brands, Llc, Neos Therapeutics, Lp, Neos Therapeutics Commercial, Llc, Pharmafab Texas, Llc, Aytu Therapeutics, Llc, Innovus Pharmaceuticals, Inc., Semprae Laboratories, Inc., Novalere, Inc., Supplement Hunt, Inc., and Delta Prime Savings Club, Inc. as Borrowers
CI
Aytu BioScience : Completes Merger With Neos Therapeutics
MT
NEOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements (form 8-K)
AQ
Neos Therapeutics, Inc. Announces Board Changes
CI
Neos Therapeutics, Inc. Announces Cessation of Richard Eisenstadt as Chief Financial Officer
CI
Neos Therapeutics, Inc. Announces Cessation of Gerald Mclaughlin as Chief Executive Officer
CI
Neos Therapeutics, Inc.(NasdaqGM:NEOS) dropped from S&P TMI Index
CI
Neos Therapeutics : Aytu BioScience Announces Close of Merger with Neos Therapeutics
PU
Neos Therapeutics, Inc.(NasdaqGM:NEOS) dropped from NASDAQ Composite Index
CI
Aytu BioScience, Inc. completed the acquisition of Neos Therapeutics, Inc..
CI
Transcript : Neos Therapeutics, Inc. - Shareholder/Analyst Call
Neos Therapeutics : Merger With Aytu BioScience Endorsed by Proxy Advisers Glass, Lewis
MT
Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience
GL
Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience
GL
Aytu BioScience : Neos Therapeutics Shareholders To Vote on Deal In March
MT
Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders Related to Proposed Merger to Be Held on March 18, 2021
GL
NEOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
Neos Therapeutics, Inc. announced that it has received $5 million in funding from Aytu BioScience, Inc.
CI
NEOS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEOS Stock
  4. News Neos Therapeutics, Inc.